Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Isatuximab Quadruplet Approval Could Change MM Landscape
RIO DE JANEIRO — Adding isatuximab, or Isa (Sarclisa, Sanofi-Aventis), to bortezomib, lenalidomide, and dexamethasone (VRd) for the treatment of patients with newly diagnosed, transplant-ineligible multiple myeloma reduced the risk for disease progression or death by more than 40% vs…
English